Skip to main content
Aurora Spine logo

Aurora Spine — Investor Relations & Filings

Ticker · ASG ISIN · CA05206X1087 TSXV Manufacturing
Open in API
Filings indexed 201 across all filing types
Latest filing 2026-04-23 Report Publication Anno…
Country CA Canada
Listing TSXV ASG

About Aurora Spine

https://www.aurora-spine.com/

Aurora Spine designs and manufactures innovative, minimally invasive spinal implants and surgical solutions. The company's mission is to simplify complex spine and SI joint procedures, focusing on patient-centric devices for aging populations. Its comprehensive product portfolio addresses conditions across the Cervical, Thoracic, Lumbar, and SI joint regions. Core offerings include the patented ZIP family of interspinous process lumbar fusion devices, known for their screwless, less invasive design. Aurora Spine is also a vertically integrated provider, offering a comprehensive biologics portfolio alongside its implant systems.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Report Publication Announcement Classification · 88% confidence The document is a press release purely announcing the timing of Aurora Spine’s Q4 and full‐year 2025 financial results filing and the associated investor conference call, without containing any actual financial results or detailed metrics. It does not present an earnings summary or transcript, but simply schedules the report publication and call. Under the “menu vs meal” rule, this short announcement that the report “will be filed” and the call “will be hosted” qualifies as a Report Publication Announcement rather than an actual earnings release or interim report.
2026-04-23 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 60% confidence The document is a TSX Trust Company notice confirming that the issuer’s Notice of Record and Meeting Dates for its upcoming Annual General and Special Meeting has been sent to the depository. It provides administrative meeting details (meeting date, record date, classes of securities, notice‐and‐access arrangements) rather than the full AGM materials or proxy statement. It does not report vote results, declare dividends, or contain financial results. It is a regulatory/administrative filing that does not neatly fit the other specific categories, so it falls under the general Regulatory Filings (RNS) category.
2026-04-13 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 75% confidence The document is a confirmation notice from TSX Trust Company detailing record and meeting dates for Aurora Spine Corporation’s upcoming Annual and Special Meeting of Security Holders. It does not contain AGM materials or presentations, nor is it the proxy statement itself. It is a regulatory notice/filing type communication for exchanges and commissions. No other specific category directly covers a meeting notice, so it falls under the general Regulatory Filings category.
2026-04-13 English
News release - English.pdf
Investor Presentation Classification · 95% confidence The document is a press release announcing the issuance of two U.S. patents for Aurora Spine Corporation. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor does it announce a report (RPA). As it is a general corporate announcement regarding business operations and intellectual property, it falls under the fallback category for regulatory announcements.
2026-01-08 English
News release - English.pdf
Earnings Release Classification · 100% confidence The document is a press release from Aurora Spine Corporation announcing its financial results for the third quarter ended September 30, 2025. It includes key financial highlights, management commentary, selected financial tables, and details for an upcoming conference call. This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of quarterly financial results to the public. Q3 2025
2025-11-18 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a 'Certification of Interim Filings' (Form 52-109FV2) signed by the CEO. This is a regulatory requirement accompanying interim financial reports to certify the accuracy of the disclosures. Since it is a regulatory filing that does not fit into the specific categories of financial reports, management presentations, or announcements, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback.
2025-11-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.